Cellular Immunology

Journal

Publication Venue For

  • Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells.  285:23-30. 2013
  • Differential expression of FCRLA in naïve and activated mouse B cells.  272:182-192. 2012
  • Defining the immunological phenotype of Fc receptor-like B (FCRLB) deficient mice: Confounding role of the inhibitory FcγRIIb.  266:24-31. 2010
  • Engagement of transgenic Ly49A inhibits mouse CD4 cell activation by disrupting T cell receptor, but not CD28, signaling.  257:88-96. 2009
  • CCR5 expression on monocytes and T cells: Modulation by transmigration across the blood-brain barrier in vitro.  243:19-29. 2006
  • α3β1 integrin induced suppression of the Caco-2 epithelial cell IL-1 signaling pathway leading to NF-κB activation.  231:30-39. 2004
  • Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection.  230:44-55. 2004
  • Impaired antigen-induced CD8 + T cell clonal expansion in aging is due to defects in antigen presenting cell function.  229:86-92. 2004
  • Immunoprotection in proestrus females following trauma-hemorrhage: The pivotal role of estrogen receptors.  222:27-34. 2003
  • Inhibition of tumor rejection by γδ T cells and IL-10.  221:107-114. 2003
  • Peptide affinity for MHC influences the phenotype of CD8+ T cells primed in vivo.  214:89-96. 2001
  • Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.  211:143-153. 2001
  • IL-1β is essential for langerhans cell activation and antigen delivery to the lymph nodes during contact sensitization: Evidence for a dermal source of IL-1β.  211:105-112. 2001
  • Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cells.  208:107-114. 2001
  • Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cells..  208:107-114. 2001
  • Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells.  195:147-156. 1999
  • Bovine insulin and porcine or human insulin prime distinct CD4+ T cell subsets in C57BL/6 mice.  195:66-74. 1999
  • Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways.  176:113-121. 1997
  • Involvement of cytokine gene expression in the age-dependent decline of NK cell response.  173:221-229. 1996
  • B cell differentiation factor-induced human B cell maturation: Stimulation of intracellular calcium release.  164:227-233. 1995
  • Germinal center T cells exhibit properties of memory helper T cells.  163:206-214. 1995
  • Modulation of MHC class II expression in human cells by dexamethasone.  165:12-19. 1995
  • IL-6 stimulates growth and inhibits constitutive, protein synthesis- independent apoptosis of murine B-cell hybridoma 7TD1.  155:428-435. 1994
  • Interleukin-6 regulates expression of the syndecan-1 proteoglycan on b lymphoid cells.  153:456-467. 1994
  • Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes.  157:158-169. 1994
  • Properties of human follicular dendritic cells purified with HJ2, a new monoclonal antibody.  155:27-41. 1994
  • Characterization of t and b cells isolated from mucosa-associated tissues of the rhesus macaque.  151:379-391. 1993
  • Transforming growth factor-β inhibits the production of IgG, IgM, and IgA in human lymphocyte cultures.  144:417-428. 1992
  • Functional properties of human germinal center B cells.  140:331-344. 1992
  • Extent of γδ T cell involvement in the pneumonia caused by sendai virus.  143:183-193. 1992
  • Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides.  143:284-297. 1992
  • Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats.  136:291-302. 1991
  • Recombinant human interleukin 6 (rhIL-6) promotes the terminal differentiation of in vivo-activated human B cells into antibody-secreting cells.  132:423-432. 1991
  • The production of growth hormone by subpopulations of rat mononuclear leukocytes.  135:55-65. 1991
  • Synergism of interleukin 7 with the thymocyte growth factors interleukin 2, interleukin 6, and tumor necrosis factor α in the induction of thymocyte proliferation.  127:470-482. 1990
  • Evidence for a δ-class opioid receptor on cells of the immune system.  116:44-51. 1988
  • Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutinin.  109:12-24. 1987
  • Inhibition of postbinding target cell lysis and of lymphokine-induced enhancement of human natural killer cell activity by in vitro exposure to ultraviolet B radiation.  104:47-58. 1987
  • Mouse monoclonal antibodies against bromelain-treated mouse erythrocytes: Reactivity with erythrocytes of various species of animals and idiotypes.  102:241-250. 1986
  • Inhibition of natural killer cell activity by IgA.  101:143-155. 1986
  • J-chain expression in human cells producing IgG subclasses.  91:515-519. 1985
  • Establishment of growth factor-dependent MOPC 104E cell line in vitro.  90:24-31. 1985
  • Generation of a soluble IFN-γ inducer by oxidation of galactose residues on macrophages.  94:440-446. 1985
  • Natural killer cells in human colostrum.  93:467-474. 1985
  • Defective spontaneous but normal antibody-dependent cytotoxicity for an extracellular protozoan parasite, Giardia lamblia, by C3H/HeJ mouse macrophages.  85:244-251. 1984
  • Human colostral cells. II. Response to mitogens.  86:222-229. 1984
  • Interferon-induced transfer of viral resistance by human B and T lymphocytes.  87:678-683. 1984
  • Regulatory mechanisms of the immune response to heterologous insulins. I. Development and regulation of plaque-forming cell responses in vitro.  87:73-84. 1984
  • Antigen presentation to human T lymphocytes. II. Requirements for Mac-120+ macrophages and responsiveness to interleukin 2.  76:379-389. 1983
  • Human host response to Giardia lamblia. II. Antibody-dependent killing in vitro.  82:308-315. 1983
  • Nonsensitized murine B lymphocytes produce mouse interferon α/β in response to foreign cells.  78:375-378. 1983
  • The proportion of TA, TG, and TM cells in various immunodeficiency and autoimmune disorders.  80:105-114. 1983
  • Bromodeoxyuridine and light treatment enhances responsiveness of pokeweed mitogen-stimulated human lymphocytes to autologous and allogeneic determinants.  72:102-112. 1982
  • Divalent cations and cytochalasin B-sensitive processes in activation, synthesis, and release of mixed leukocyte reaction suppressor factor.  61:353-364. 1981
  • Oral-parenteral immunization leads to the appearance of IgG auto-anti-idiotypic cells in mucosal tissues.  60:498-502. 1981
  • Role of calcium and magnesium and of cytochalasin-sensitive processes in lectin-stimulated lymphocyte activation.  59:276-288. 1981
  • Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.  49:390-394. 1980
  • Tissue distribution of IgA receptor-bearing cells in mouse and guinea pig with special reference to the lymphoid population of the gastrointestinal tract.  55:106-113. 1980
  • Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells.  43:197-201. 1979
  • Inhibition of lectin-induced lymphocyte activation by diamide and other sulfhydryl reagents.  36:303-311. 1978
  • Sulfhydryl compounds potentiate lectin induced increases in cyclic AMP in human peripheral lymphocytes.  28:338. 1977
  • Separation of mitogen-induced suppressor and helper cell activities during inhibition of interferon production by cyclic AMP.  33:170-179. 1977
  • Suppression of mixed lymphocyte reactions by alloantigen-activated spleen-localizing thymocytes.  22:358-368. 1976
  • Scanning electron microscopy of normal and mitogen-stimulated mouse lymphoid cells.  19:336-348. 1975
  • Cyclic variations in cell-mediated immunity to skin allografts detected by the technetium-99m microcytotoxicity assay.  13:472-483. 1974
  • The use of technetium-99m as a radioisotopic label to assess cell-mediated immunity in vitro.  10:38-49. 1974
  • Simultaneous suppression of responses to allogeneic tissue in vitro and in vivo.  5:190-200. 1972
  • International Standard Serial Number (issn)

  • 0008-8749
  • Electronic International Standard Serial Number (eissn)

  • 1090-2163